Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Koopman

Showing results (221-230 of 385) with videos related to

Pageof 39
Sort By:
Caries Research|February 12, 2014
The effects of propidium monoazide treatment on the measured composition of polymicrobial biofilms after treatment with chlorhexidineR A M Exterkate, E Zaura, M J Buijs, et al.
The Journal of Rheumatology|November 1, 1996
Recombinant soluble tumor necrosis factor receptor (p80) fusion protein: toxicity and dose finding trial in refractory rheumatoid arthritisL W Moreland, G Margolies, L W Heck, et al.
Arthritis and Rheumatism|July 1, 1984
Rheumatoid myositis. Clinical and histologic features and possible pathogenesisJ T Halla, W J Koopman, S Fallahi, et al.
Arthritis and Rheumatism|January 1, 1990
Correlation of serologic indicators of inflammation with effectiveness of nonsteroidal antiinflammatory drug therapy in rheumatoid arthritisJ J Cush, P E Lipsky, A E Postlethwaite, et al.
Brain : a Journal of Neurology|April 29, 1999
The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosisD A Cottrell, M Kremenchutzky, G P Rice, et al.
The Journal of Rheumatology|October 1, 1993
Anticardiolipin antibodies in systemic lupus erythematosus: clinical correlates, HLA associations, and impact on survivalP S Gulko, J D Reveille, W J Koopman, et al.
Journal of the Neurological Sciences|June 1, 1993
Severe axonal degeneration in acute Guillain-Barré syndrome: evidence of two different mechanisms?T E Feasby, A F Hahn, W F Brown, et al.
Clinical and Experimental Rheumatology|March 1, 1993
Antifolates in rheumatoid arthritis: a hypothetical mechanism of actionJ E Baggott, S L Morgan, T S Ha, et al.
The Journal of Rheumatology|February 1, 1994
Survival impact of autoantibodies in systemic lupus erythematosusP S Gulko, J D Reveille, W J Koopman, et al.
Rheumatic Diseases Clinics of North America|August 1, 1987
Analysis of restriction fragment length polymorphisms in rheumatic diseasesD O McDaniel, B O Barger, J D Reveille, et al.
Pageof 39

Showing results (221-230 of 385) with videos related to

Sort By:
Pageof 39
Caries Research|February 12, 2014
The effects of propidium monoazide treatment on the measured composition of polymicrobial biofilms after treatment with chlorhexidineR A M Exterkate, E Zaura, M J Buijs, et al.
The Journal of Rheumatology|November 1, 1996
Recombinant soluble tumor necrosis factor receptor (p80) fusion protein: toxicity and dose finding trial in refractory rheumatoid arthritisL W Moreland, G Margolies, L W Heck, et al.
Arthritis and Rheumatism|July 1, 1984
Rheumatoid myositis. Clinical and histologic features and possible pathogenesisJ T Halla, W J Koopman, S Fallahi, et al.
Arthritis and Rheumatism|January 1, 1990
Correlation of serologic indicators of inflammation with effectiveness of nonsteroidal antiinflammatory drug therapy in rheumatoid arthritisJ J Cush, P E Lipsky, A E Postlethwaite, et al.
Brain : a Journal of Neurology|April 29, 1999
The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosisD A Cottrell, M Kremenchutzky, G P Rice, et al.
The Journal of Rheumatology|October 1, 1993
Anticardiolipin antibodies in systemic lupus erythematosus: clinical correlates, HLA associations, and impact on survivalP S Gulko, J D Reveille, W J Koopman, et al.
Journal of the Neurological Sciences|June 1, 1993
Severe axonal degeneration in acute Guillain-Barré syndrome: evidence of two different mechanisms?T E Feasby, A F Hahn, W F Brown, et al.
Clinical and Experimental Rheumatology|March 1, 1993
Antifolates in rheumatoid arthritis: a hypothetical mechanism of actionJ E Baggott, S L Morgan, T S Ha, et al.
The Journal of Rheumatology|February 1, 1994
Survival impact of autoantibodies in systemic lupus erythematosusP S Gulko, J D Reveille, W J Koopman, et al.
Rheumatic Diseases Clinics of North America|August 1, 1987
Analysis of restriction fragment length polymorphisms in rheumatic diseasesD O McDaniel, B O Barger, J D Reveille, et al.
Pageof 39